BioSpace News Archive

ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, announced that the Company will release its financial results for the second quarter ended June 30, 2021 and provide a corporate strategic update on Thursday, August 12, 2021, after the close of trading.

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced second quarter 2021 financial results and provided an operational update.

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, plans to report second quarter 2021 financial results after the close of market on Thursday, August 12, 2021.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, provides a corporate update and reports financial results for the three and six months ended June 30, 2021.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, reported its financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent highlights for the second quarter ended June 30, 2021.

Everest Medicines announced that the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China has approved a Clinical Trial Application for XeravaTM for the treatment of community-acquired bacterial pneumonia.

The demand within the global market for ventricular assist devices has been rising on account of the rising incidence of cardiovascular diseases, finds Transparency Market Research.

The vendor landscape in the global IT spending on clinical analytics market is a mix of regional and international players.